WELCOME TO Million Health Pharmaceuticals

The reoccurrence of HBV ailment happens in patients who are contaminated with HBV/HCV co infection. This may neutralized by; Investigate the patients HBsAg and threatening to HBc levels before beginning the treatment. Liver limit test should be take a gander at as frequently as would be prudent The prosperity organization related to HBV infection should be started.

The most common indication of Sovihep V is involved in the treatment of chronic hepatitis C viral infection associated with genotypes I to VI.

Sovihep V tablets works

Sofosbuvir is a NS5B protein inhibitor; protein is essential for viral age. Sofosbuvir is a prodrug shape, which get changed over into dynamic uridine triphosphate outline which is required for against viral development. This dynamic moiety is getting implanted into HCV RNA with the help of NS5B polymerase and leads as chain eliminator. Velpatasvir is pharmacologically goes about as NS5A inhibitor; this protein is required for HCV viral age. Velpatasvir is incorporated its action in viral age process. The major mechanism of Sovihep V is involved in prohibition of viral production by intercedes the NS5A & NS5B proteins.


Maximum plasma concentration time: Sofosbuvir 0.5 to 1 hour & Velpatasvir 3 hours. Sovihep V should be given with food or without food. Human protein binding nature of Sovihep V : Sofosbuvir 61 to 65% & Velpatasvir >99.5% & the circulating metabolite of Sofosbuvir is GS-331007 has low binding effect.

Sovihep V metabolism occurs in liver, with the help of cathepsin A, carboxyl esterase 1for sofosbuvir; CYP2B6, CYP2C8 or CYP3A4 for Velpatasvir. Excretion of Sovihep V should be occurs through glomerular filteration & active tubular secretion & biliary excretion.

Sofosbuvir doses are eliminated via urine as 80%, feces as 14% & exhaled air as 2.5%. Velpatasvir doses are eliminated via urine as 0.4% & feces as 94%.

The half life period of Sovihep V is; Sofosbuvir 0.4 hour GS-331007: 27 hours Velpatasvir: 15 hours


Brand : Sovihep V
Ingredients : Sofosbuvir & Velpatasvir
Strength : 400mg & 100mg
Manufactured : Zydus
Package : 28 tablets

Before start the therapy

Explore the patients altogether, before beginning the treatment with HCV hostile to viral specialists. Alert ought to be taken while utilizing HCV medicines in patients with HCV/HIV-1co contaminations, for this situation HBV revival happens. Sovihep V tablets are suggested for perpetual state of hepatitis C viral contamination caused by genotype 1, 2, 3, 4, 5 or 6. The dosing regimens of Sovihep V ; The typical endorsed dosage of Sovihep V is, one tablet ought to be taken orally as an once every day. Sovihep V tablet contains 100mg of Velpatasvir and 400mg of Sofosbuvir

Over dosage

At the time of over dose, patients must be furnished with general consistent treatment. Over dosage should be managed by hemodialysis. Velpatasvir is hard to remove by dialysis process since it is uncommonly connections to human plasma protein. Sofosbuvir revolving around metabolites get abstained from through dialysis with extent of 53%.

Therapy duration
Patients with compensated cirrhosis or without cirrhosis

One tablet of Sovihep V should be administered orally as once daily over period of 12 weeks.

Patients with decompensated cirrhosis

One Sovihep V tablet should be combined with weight based ribavirin by administering with food for 12 hours.

The dose of ribavirin should be calculated for the patients

Patient with <75kg of body weight, the recommended dose of ribavirin is 1000mg administered as twice daily. Patient with at least 75kg of body weight, recommended dose of ribavirin is 1200mg administered as twice daily. For both renal & hepatic impaired patients; Sovihep V tablets dosage adjustment should not be recommended.

Unfavorable effects

Serious bradycardia occurs due to concomitant use of Sovihep V with amiodarone. Insomnia Irritability Headache Fatigue Nausea Asthenia

Lab abnormalities

Lipase elevation Elevation of creatine kinase Elevation of bilirubin levels

Post marketing effects

Cardiac disorders Rashes Angioedema


This opposing occurs by mix of Sovihep V with amiodarone; causes extended joining of amiodarone prompts outrageous bradycardia. To overcome the issue by; Stop the combinational treatment ECG checking Start supportive medication for decreasing the cardiovascular issues

Loss of impact because of blend of Sovihep V with P-gp inducers

The synchronous use of Sovihep V with P-gp inducers causes loss of therapeutic activity of Sovihep V .

Utilization of ribavirin with Sovihep V

Fetal mischief condition is a result of the orderly usage of Sovihep V with ribavirin in the midst of pregnancy period.



The combination of Sovihep V with P-gp inducers potent produces lack of anti-viral activity due to diminished concentration of sofosbuvir. The co administration of Sovihep V with P-gp or BCRP inhibitors causes exposure of adverse effects associated with these substrates. The concurrent of Sovihep V with warfarin causes fluctuation in prothrombin time or INR values.

The co administration of Sovihep V with acid reducing agents should be avoided; this may causes loss of activity by reducing the concentration of ingredients in Sovihep V The combination of Sovihep V with amiodarone should be abstained. This combination causes bradycardia.

The concurrent use of Sovihep V with anti-convulsants or anti-mycobacterials causes diminishing the concentration of Velpatasvir or sofosbuvir. The concomitant use of Sovihep V with st Johns wort causes loss of activity of Sovihep V due to decreased concentration of ingredients of Sovihep V The combination of Sovihep V with HMG CoA reductase inhibitors causes increasing the concentration of these drugs.

abdominal pain
abdominal pain
concluded as death
concluded as death
dark urine
dark urine
flu like syndrome
flu like syndrome
loss of apetite
loss of apetite
loss of weight
loss of weight

Quick Contact

Prescription upload

Top Products


Millionpharma.com , a fully licensed and regulated pharmacy medicine, takes all precautions to strictly abide by the laws and regulations set forth in the dispensing of prescription medications. By placing the order for your prescription medicines, you acknowledge and accept the following terms regarding the purchase of any prescription medicines.

Millionpharma.com will not dispense any prescription medication without a valid prescription from a licensed physician.

If you are ordering prescription medication(s), you hereby confirm that you will send us a scanned copy of your valid prescription(s) via email, fax, Whatsapp, or by post, and this prescription shall then be subject to the scrutiny of and approval by our qualified Pharmacists.

The drug information provided in the Millionpharma.com is for informative purposes only and this Website is not intended to provide diagnosis, treatment or medical advice. We are not liable for any adverse effects or harm to you as a result of your reliance on the information in the Website.

Millionpharma.com requires either the User or Customer or the Caregiver to confirm he/she is completely aware of the indications, side effects, drug interactions, effects of missed dose or overdose of the medicines he/she orders from us. It is imperative to seek professional advice from your physician before purchasing or consuming any medicine from Millionpharma.com

At Millionpharma.com , a Caregiver can order prescription medicines on your behalf.


This information should not be used to decide whether or not to take this Product or any other medicine. Only the healthcare provider has the knowledge and training to decide which medicines are right for a specific patient. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this Product . It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from the healthcare provider. You must talk with the healthcare provider for complete information about the risks and benefits of using this product.